Trial NCT00637481

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Chemoprevention is the use of certain drugs to keep cancer from forming. The use of
atorvastatin (Lipitor) may prevent breast cancer. This randomized phase I trial is studying
the best dose of atorvastatin in preventing breast cancer in women at increased risk for
breast cancer.

Intervention

atorvastatin calcium, laboratory biomarker analysis

Condition

Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ

Investigators

See list of participating sites